GSK plc announced the purchase of 420,000 ordinary shares at prices ranging from 2,189.00p to 2,259.00p on February 17, 2026, as part of its buyback program. This brings their treasury shares to 240,311,094 out of a total of 4,075,831,475 shares issued.